Status: Phase 2
Entry Type: Antibody
Molecule Category: UNKNOWN

Indications

Mesh Heading Maximum Phase Reference
Multiple Sclerosis; Sclerosis Phase 1 ClinicalTrials
Neoplasms Phase 1 ClinicalTrials
Melanoma; Skin Neoplasms Phase 1 ClinicalTrials
Melanoma; Skin Neoplasms Phase 1 ClinicalTrials
Head and Neck Neoplasms; Squamous Cell Carcinoma of Head and Neck Phase 1 ClinicalTrials
Huntington Disease Phase 2 ClinicalTrials
Carcinoma, Non-Small-Cell Lung Phase 1/Phase 2 ClinicalTrials
Adenocarcinoma; Carcinoma; Colorectal Neoplasms; Pancreatic Neoplasms Phase 1 ClinicalTrials
CONTENTS